Clinical trial
A Phase 1b, Randomized, Partially Double-blind, Placebo-controlled Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With RSV Infection
NCT02593851 is registered in ClinicalTrials.gov with Janssen Sciences Ireland UC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1b, Randomized, Partially Double-blind, Placebo-controlled Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With RSV Infection
- Lead sponsor
- Janssen Sciences Ireland UC
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- December 4, 2015
- Completion date
- November 10, 2017
- Enrollment
- 45 (actual)
- Sites
- 39
Conditions
As the registry lists them; a condition with its own page is linked.